---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-000198"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2023-01-04T23:59:59+00:00"
generated_at: "2026-06-20T20:08:28.943300+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma raises $6.5M in registered direct offering of shares and warrants at $1.00 per unit

## Summary
- Offering of 6.5M shares or pre-funded warrants plus 6.5M warrants to purchase common stock.
- Gross proceeds of $6.5 million, before placement agent fees and expenses.
- Warrants exercisable at $1.00 per share, beginning six months after issuance, for five years.
- H.C. Wainwright & Co. acted as exclusive placement agent; cash fee of $390,000 paid.
- Net proceeds to be used for general corporate purposes; closing expected January 4, 2023.

## SEC filing metadata
- accession: 0001493152-23-000198
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2023-01-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/0001493152-23-000198-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-000198
- JSON: https://secwatch.observer/filing/0001493152-23-000198.json
- Plain text: https://secwatch.observer/filing/0001493152-23-000198.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.